Setrobuvir
Setrobuvir
Setrobuvir (pronounced: set-ro-bu-vir) is an experimental antiviral drug that is primarily used in the treatment of Hepatitis C. It is a non-nucleoside NS5B polymerase inhibitor, which means it works by inhibiting the replication of the Hepatitis C virus.
Etymology
The name "Setrobuvir" is derived from the drug's mechanism of action. "Setro" is a prefix used in pharmacology to denote drugs that inhibit or block a certain action, while "buvir" is a suffix commonly used for antiviral drugs.
Mechanism of Action
Setrobuvir works by inhibiting the NS5B RNA-dependent RNA polymerase, an essential protein for the replication of the Hepatitis C virus. By blocking this protein, Setrobuvir prevents the virus from replicating and spreading within the body.
Related Terms
- Antiviral drug: A type of medication used to treat viral infections.
- Hepatitis C: A viral infection that causes liver inflammation and damage.
- NS5B polymerase: An enzyme that is essential for the replication of the Hepatitis C virus.
- RNA-dependent RNA polymerase: An enzyme that catalyzes the replication of RNA from an RNA template.
Side Effects
Like all medications, Setrobuvir can cause side effects. The most common side effects include fatigue, headache, and nausea. More serious side effects can include liver damage and severe allergic reactions.
Clinical Trials
Setrobuvir has undergone several clinical trials to test its efficacy and safety in treating Hepatitis C. The results of these trials have been promising, with many patients showing a significant reduction in viral load.
External links
- Medical encyclopedia article on Setrobuvir
- Wikipedia's article - Setrobuvir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski